To the best of our knowledge, this study is the first to describe the presence of activated PKCα in the urine of orthotopic xenograft mice and demonstrates that activated PKCα can be used as a urinary biomarker for the diagnosis of bladder cancer. Here, PRKCA is linked to urinary bladder carcinoma.